Cannabis use and mood disorders: a systematic review
Frontiers in Public Health · 09.04.2024 · 12
DOI: 10.3389/fpubh.2024.1346207 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Public Health, online erschienen am 09.04.2024. Verfasst von Maryam Sorkhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Mental Health Policy and Research at CAMH, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Major Depressive Disorder. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
Background
Problematic cannabis use is highly prevalent among people with mood disorders. This underscores the need to understand the effects of cannabis and cannabinoids in this population, especially considering legalization of recreational cannabis use.
Objectives
We aimed to (1) systematically evaluate cross-sectional and longitudinal studies investigating the interplay between cannabis use, cannabis use disorder (CUD), and the occurrence of mood disorders and symptoms, with a focus on major depressive disorder (MDD) and bipolar disorder (BD) and; (2) examine the effects of cannabis on the prognosis and treatment outcomes of MDD and BD.
Methods
Following PRISMA guidelines, we conducted an extensive search for English-language studies investigating the potential impact of cannabis on the development and prognosis of mood disorders published from inception through November 2023, using EMBASE, PsycINFO, PubMed, and MEDLINE databases.
Results
Our literature search identified 3,262 studies, with 78 meeting inclusion criteria. We found that cannabis use is associated with increased depressive and manic symptoms in the general population in addition to an elevated likelihood of developing MDD and BD. Furthermore, we observed that cannabis use is linked to an unfavorable prognosis in both MDD or BD.
Discussion
Our findings suggest that cannabis use may negatively influence the development, course, and prognosis of MDD and BD. Future well-designed studies, considering type, amount, and frequency of cannabis use while addressing confounding factors, are imperative for a comprehensive understanding of this relationship. Systematic review registration https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023481634 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Mental Health Policy and Research at CAMH, Toronto, ON, Canada.
- Department of Psychiatry, Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
- Department of Psychology, McGill University, Montreal, QC, Canada.
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Sorkhou, M., Dent, E. L., & George, T. P. (2024). Cannabis use and mood disorders: a systematic review. Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1346207
Vancouver
Sorkhou M, Dent EL, George TP. Cannabis use and mood disorders: a systematic review. Frontiers in Public Health. 2024;12. doi:10.3389/fpubh.2024.1346207
BibTeX
@article{Sorkhou2024,
author = {Sorkhou, Maryam and Dent, Eliza L and George, Tony P},
title = {Cannabis use and mood disorders: a systematic review},
journal = {Frontiers in Public Health},
year = {2024},
volume = {12},
doi = {10.3389/fpubh.2024.1346207}
}
EUVIMED